Related Experiment Videos

Respiratory diseases in cyclophosphamide-treated mice. I. Increased virulence of Mycoplasma pulmonis

Insights

Suppressing immunity with cyclophosphamide transformed a mild Mycoplasma pulmonis infection in mice into a lethal one. This highlights the critical role of the immune system in controlling bacterial infections and enabling recovery.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Mycoplasma pulmonis causes chronic respiratory infections in mice.
  • The immune system is crucial for controlling Mycoplasma infections.

Purpose of the Study:

  • To investigate the role of immunity in Mycoplasma pulmonis infection using an immunosuppression model.
  • To determine the impact of cyclophosphamide on infection dynamics and mortality.

Main Methods:

  • Mice were infected intranasally with Mycoplasma pulmonis.
  • Mice were treated with cyclophosphamide, an immunosuppressive drug.
  • Mycoplasma pulmonis dissemination and titers were monitored.
  • Reconstitution experiments with spleen cells were performed.

Main Results:

  • Cyclophosphamide treatment increased mortality from 2% to 66%.
  • Immunosuppression led to earlier dissemination and higher Mycoplasma titers.
  • Spleen cell reconstitution reversed the lethal effects of cyclophosphamide.

Conclusions:

  • Immunity is essential for containing Mycoplasma pulmonis infection.
  • Immunosuppression significantly exacerbates Mycoplasma pulmonis infections.
  • Immune cells play a key role in recovery from Mycoplasma pulmonis.

Related Concept Videos